Search Results - Katherine A. Janeway

Refine Results
  1. 1
    Future directions in the treatment of osteosarcoma

    Future directions in the treatment of osteosarcoma by Michael W. Bishop, Katherine A. Janeway, Richard Görlick

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Precision medicine in pediatric oncology

    Precision medicine in pediatric oncology by Suzanne J. Forrest, Birgit Geoerger, Katherine A. Janeway

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Children's Oncology Group's 2013 blueprint for research: Bone tumors

    Children's Oncology Group's 2013 blueprint for research: Bone tumors by Richard Görlick, Katherine A. Janeway, Stephen L. Lessnick, R. Lor Randall, Neyssa Marina

    Published 2012
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without <i>IGF1R</i> genomic amplification

    Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without <i>IGF1R</i> genomic amplification by Katherine A. Janeway, Mei‐Jun Zhu, Jordi Barretina, Antonio R. Pérez‐Atayde, George D. Demetri, Jonathan A. Fletcher

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal Tumors

    Pediatric <i>KIT</i>–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progressio... by Katherine A. Janeway, Bernadette Liegl, Amy Harlow, Claudia Le, Antonio R. Pérez‐Atayde, Harry Kozakewich, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group

    Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group by Holly Spraker‐Perlman, Donald A. Barkauskas, Mark Krailo, Paul A. Meyers, Cindy L. Schwartz, John J. Doski, Richard Görlick, Katherine A. Janeway, Michael S. Isakoff

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience

    Patient/parent perspectives on genomic tumor profiling of pediatric solid tumors: The Individualized Cancer Therapy (iCat) experience by Jonathan M. Marron, Steven G. DuBois, Julia Glade Bender, AeRang Kim, Brian D. Crompton, Stephanie C. Meyer, Katherine A. Janeway, Jennifer W. Mack

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Outcome for adolescent and young adult patients with osteosarcoma

    Outcome for adolescent and young adult patients with osteosarcoma by Katherine A. Janeway, Donald A. Barkauskas, Mark Krailo, Paul A. Meyers, Cindy L. Schwartz, David H. Ebb, Nita L. Seibel, Holcombe E. Grier, Richard Görlick, Neyssa Marina

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial

    Target and Agent Prioritization for the Children’s Oncology Group—National Cancer Institute Pediatric MATCH Trial by Carl E. Allen, Theodore W. Laetsch, Rajen Mody, Meredith S. Irwin, Megan S. Lim, Peter C. Adamson, Nita L. Seibel, D. Williams Parsons, Y. Jae Cho, Katherine A. Janeway

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

    Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor... by Michael W. Bishop, Yu‐Chen Chang, Mark Krailo, Paul A. Meyers, Arthur J. Provisor, Cindy L. Schwartz, Neyssa Marina, Lisa A. Teot, Mark C. Gebhardt, Richard Görlick, Katherine A. Janeway, Alexander J. Chou

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study

    Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study by Pam K. Mangat, Susan Halabi, Suanna S. Bruinooge, Elizabeth Garrett‐Mayer, Ajjai Alva, Katherine A. Janeway, Philip J. Stella, Emile E. Voest, Kathleen J. Yost, Jane Perlmutter, Navin Pinto, Edward S. Kim, Richard L. Schilsky

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood

    Von Hippel–Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood by Surya P. Rednam, Ayelet Erez, Harriet Druker, Katherine A. Janeway, Junne Kamihara, Wendy Kohlmann, Katherine L. Nathanson, Lisa J. States, Gail E. Tomlinson, Anita Villani, Stephan D. Voss, Joshua D. Schiffman, Jonathan D. Wasserman

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

    Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Childre... by Lisa M. Kopp, Suman Malempati, Mark Krailo, Yun Gao, Allen Buxton, Brenda J. Weigel, Thomas Hawthorne, Elizabeth Crowley, Jeffrey A. Moscow, Joel M. Reid, Víctor M. Villalobos, R. Lor Randall, Richard Görlick, Katherine A. Janeway

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Characterization of a novel fusion gene<i>EML4</i>-<i>NTRK3</i>in a case of recurrent congenital fibrosarcoma

    Characterization of a novel fusion gene<i>EML4</i>-<i>NTRK3</i>in a case of recurrent congenital fibrosarcoma by Sarah Tannenbaum-Dvir, Julia Glade Bender, Alanna J. Church, Katherine A. Janeway, Marian H. Harris, Mahesh Mansukhani, Péter L. Nagy, Stuart Andrews, Vundavalli V. Murty, Angela V. Kadenhe‐Chiweshe, Eileen P. Connolly, Andrew L. Kung, Filemon S. Dela Cruz

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward

    Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning... by Joanne P. Lagmay, Mark Krailo, Ha Dang, AeRang Kim, Douglas S. Hawkins, Orren Beaty, Brigitte C. Widemann, Theodore Zwerdling, Lisa Bomgaars, Anne‐Marie Langevin, Holcombe E. Grier, Brenda J. Weigel, Susan M. Blaney, Richard Görlick, Katherine A. Janeway

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic

    Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic by Christopher B. Weldon, Arin L. Madenci, Sosipatros A. Boikos, Katherine A. Janeway, Suzanne George, Margaret von Mehren, Alberto S. Pappo, Joshua D. Schiffman, Jennifer Wright, Jonathan C. Trent, Karel Pacák, Constantine A. Stratakis, Lee J. Helman, Michael P. LaQuaglia

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors

    Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors by Kelly S. Klega, Alma Imamović, Gavin Ha, Andrea Clapp, Stephanie C. Meyer, Abigail Ward, Catherine Clinton, Anwesha Nag, Eliezer M. Van Allen, Elizabeth A. Mullen, Steven G. DuBois, Katherine A. Janeway, Matthew Meyerson, Aaron R. Thorner, Brian D. Crompton

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force

    Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force by Kelly M. Bailey, Carrye Cost, Ian J. Davis, Julia Glade Bender, Patrick J. Grohar, Peter J. Houghton, Michael S. Isakoff, Elizabeth Stewart, Nadia N. Laack, Jason T. Yustein, Damon R. Reed, Katherine A. Janeway, Richard Görlick, Stephen L. Lessnick, Steven G. DuBois, Pooja Hingorani

    Published 2019
    Get full text Get full text
    Pré-impressão
    Save to List
    Saved in:
  19. 19
    Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study

    Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study by Margaret von Mehren, Suzanne George, Michael C. Heinrich, Scott M. Schuetze, Jeffrey T. Yap, J Yu, Amanda Abbott, Samuel Litwin, John Crowley, Martin G. Belinsky, Katherine A. Janeway, Jason L. Hornick, Douglas B. Flieder, Rashmi Chugh, Lori Rink, Annick D. Van den Abbeele

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

    MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32 by Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway, Katherine E. Hill, Eleanor Howe, Jeffrey D. Goldsmith, Kyle C. Kurek, Antonio R. Pérez‐Atayde, Nancy Francoeur, Jian‐Bing Fan, Craig April, Hal E. Schneider, Mark C. Gebhardt, Aedín C. Culhane, John Quackenbush, Dimitrios Spentzos

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: